ReGen Therapeutics Plc: Issue of Equity | Company Announcements

Wednesday 02 September, 2009

ReGen Therapeutics Plc

Issue of Equity





For immediate release
2 September 2009

                       ReGen Therapeutics Plc
Issue of Equity

ReGen Therapeutics  Plc  ("ReGen"  or the  "Company"),  (AIM:RGT)  is
pleased to announce  that it has  conditionally placed 3,000,000  new
ordinary shares at  4p per  ordinary share to  raise £120,000  before
expenses for general working capital purposes.

The 3,000,000 new ordinary shares, which will represent 8.76 per cent
of the enlarged  issued share  capital of the  Company (in  aggregate
amounting  to  34,229,882  ordinary  shares  on  completion  of   the
placing), will  rank pari  passu in  all respects  with the  existing
ordinary shares in the Company.

Percy Lomax Chairman and Chief Executive commented:

'So far  this year  ReGen  has raised  £613,185.   We note  that  the
placing is at a share price a  third higher than at the last  placing
and believe this reflects investor confidence in the Company.

Application has been made  to the London Stock  Exchange for the  new
ordinary shares to  be admitted to  trading on AIM  and admission  is
expected to commence on or around 8 September 2009.

For further information, please contact:

Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920

Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396



ENDS

---END OF MESSAGE---




This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.

Investegate takes no responsibility for the accuracy of the information within the site.

The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.